1.3(top 50%)
impact factor
10.5K(top 2%)
papers
78.4K(top 5%)
citations
88(top 5%)
h-index
1.3(top 50%)
extended IF
11.6K
all documents
81.3K
doc citations
116(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1PET versus SPECT: strengths, limitations and challengesNuclear Medicine Communications2008662
299Tcm sestamibi — a new agent for parathyroid imagingNuclear Medicine Communications1989419
3Guidelines for the measurement of glomerular filtration rate using plasma samplingNuclear Medicine Communications2004267
4A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)Nuclear Medicine Communications1992255
5111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarctionNuclear Medicine Communications2003202
6FDG uptake, tumour characteristics and response to therapyNuclear Medicine Communications1998177
7Subtraction ictal SPET co-registered to MRI in partial epilepsyNuclear Medicine Communications1998174
8Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphyNuclear Medicine Communications2001173
9Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histologyNuclear Medicine Communications2007168
10FDG PET in the diagnosis of hilar cholangiocarcinomaNuclear Medicine Communications2001153
11Nuclear medicine imaging of bone infectionsNuclear Medicine Communications2006151
12Review of functional/anatomical imaging in oncologyNuclear Medicine Communications2012148
13Meta-analysis of 11C-choline and 18F-choline PET/CT for management of patients with prostate cancerNuclear Medicine Communications2014146
14The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prosthesesNuclear Medicine Communications2002144
15Whole-body 18F-FDG PET for the evaluation of patients with Hodgkinʼs disease and non-Hodgkinʼs lymphomaNuclear Medicine Communications1999142
16Determination of the prognostic value of [18F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancerNuclear Medicine Communications2002141
17Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?Nuclear Medicine Communications2007138
18Repeatability and reproducibility of phase analysis of gated single-photon emission computed tomography myocardial perfusion imaging used to quantify cardiac dyssynchronyNuclear Medicine Communications2008137
19Technegas - a new ventilation agent for lung scanningNuclear Medicine Communications1986136
20Value of FDG PET in patients with fever of unknown originNuclear Medicine Communications2001136
21Clinical outcome of radiosynoviorthesis: a meta-analysis including 2190 treated jointsNuclear Medicine Communications2002136
22Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation?Nuclear Medicine Communications2004136
23Diagnosis of chronic thromboembolic pulmonary hypertensionNuclear Medicine Communications2012136
24Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphomaNuclear Medicine Communications1998134
25Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG)Nuclear Medicine Communications2001133
26Unexpected 99mTc-tetrofosmin findings during myocardial perfusion scintigraphy: intraindividual comparison with PET/computed tomographyNuclear Medicine Communications2008133
2718F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancerNuclear Medicine Communications2010129
28Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imagingNuclear Medicine Communications2016126
29Is a lung perfusion scan obtained by using single photon emission computed tomography able to improve the radionuclide diagnosis of pulmonary embolism?Nuclear Medicine Communications2002125
30Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67Nuclear Medicine Communications2002125
31Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imagingNuclear Medicine Communications2015125
32Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinomaNuclear Medicine Communications2014124
33The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspectiveNuclear Medicine Communications2004123
34Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumoursNuclear Medicine Communications2006123
35Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CTNuclear Medicine Communications2015123
36Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy schemeNuclear Medicine Communications2001121
37Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysisNuclear Medicine Communications2009120
38FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablationNuclear Medicine Communications2001119
39Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomographyNuclear Medicine Communications2009119
40Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imagingNuclear Medicine Communications1985118
41Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PETNuclear Medicine Communications2004118
42SPECT neuropsychological activation procedure with the Verbal Fluency Test in attempted suicide patientsNuclear Medicine Communications2002116
43Conversion of brain SPECT images between different collimators and reconstruction processes for analysis using statistical parametric mappingNuclear Medicine Communications2004115
44Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imagingNuclear Medicine Communications2009115
45A 99Tcm-labelled radiotracer for the investigation of cerebral vascular diseaseNuclear Medicine Communications1985110
46A technique for using CT images in attenuation correction and quantification in SPECTNuclear Medicine Communications1989110
47Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experienceNuclear Medicine Communications2004110
48Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infectionNuclear Medicine Communications2003109
49Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinomaNuclear Medicine Communications2004109
50Whole-body PET/CT: Spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patientsNuclear Medicine Communications2005109